Hypertension effective treatment coverage (controlled hypertension) in South-East Asia (WHO region)
South-East Asia (WHO region): Hypertension effective treatment coverage (controlled hypertension) was 13.6% in 2019. ◆ Volatile
Latest (2019)
13.6%
Change on year
up 5.4%
Rank
9th
of 11 groups
All-time high
13.6%
in 2019
All-time low
1.9%
in 1990
Years of data
30
1990–2019
Hypertension effective treatment coverage (controlled hypertension) in South-East Asia (WHO region), 1990–2019
Source: World Health Organization, Global Health Observatory.
Analysis
In 2019, hypertension effective treatment coverage (controlled hypertension) in South-East Asia (WHO region) stood at 13.6%. That is the highest value across all 30 years on record.
That represents a change of up 5.4% on the previous year and up 70.0% over ten years.
Over the whole period, hypertension effective treatment coverage (controlled hypertension) in South-East Asia (WHO region) peaked at 13.6% in 2019 and was at its lowest, 1.9%, in 1990.
The series is highly variable year to year, so single readings are best treated with caution.
Hypertension effective treatment coverage (controlled hypertension) in South-East Asia (WHO region), year by year
| Year | Value | Change |
|---|---|---|
| 1990 | 1.9% | — |
| 1991 | 1.9% | +0.0% |
| 1992 | 2.0% | +5.3% |
| 1993 | 2.2% | +10.0% |
| 1994 | 2.3% | +4.5% |
| 1995 | 2.5% | +8.7% |
| 1996 | 2.7% | +8.0% |
| 1997 | 2.9% | +7.4% |
| 1998 | 3.2% | +10.3% |
| 1999 | 3.5% | +9.4% |
| 2000 | 3.8% | +8.6% |
| 2001 | 4.2% | +10.5% |
| 2002 | 4.5% | +7.1% |
| 2003 | 5.0% | +11.1% |
| 2004 | 5.4% | +8.0% |
| 2005 | 5.9% | +9.3% |
| 2006 | 6.4% | +8.5% |
| 2007 | 6.9% | +7.8% |
| 2008 | 7.5% | +8.7% |
| 2009 | 8.0% | +6.7% |
| 2010 | 8.5% | +6.2% |
| 2011 | 9.0% | +5.9% |
| 2012 | 9.5% | +5.6% |
| 2013 | 10.1% | +6.3% |
| 2014 | 10.6% | +5.0% |
| 2015 | 11.2% | +5.7% |
| 2016 | 11.7% | +4.5% |
| 2017 | 12.3% | +5.1% |
| 2018 | 12.9% | +4.9% |
| 2019 | 13.6% | +5.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 2.5% | 1.9% | 3.5% | 10 |
| 2000s | 5.8% | 3.8% | 8.0% | 10 |
| 2010s | 10.9% | 8.5% | 13.6% | 10 |
Countries ranked near South-East Asia (WHO region)
More health data for South-East Asia (WHO region)
- Diphtheria - number of reported cases, gaps filled 3,416 (2025)
- Total tetanus - number of reported cases, gaps filled 164 (2025)
- Pertussis - number of reported cases, gaps filled 2,449 (2025)
- Measles - number of reported cases, gaps filled 19,075 (2025)
- Neonatal tetanus - number of reported cases, gaps filled 84 (2025)
- Number of neonatal deaths, annual growth rate -4.57 % change on previous year (2024)
- Number of infant deaths, annual growth rate -4.21 % change on previous year (2024)
- Number of under-five deaths, annual growth rate -4.64 % change on previous year (2024)
- Measles - number of reported cases, annual growth rate -30.44 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -67.98 % change on previous year (2025)
Frequently asked questions
- What is hypertension effective treatment coverage (controlled hypertension) in South-East Asia (WHO region)?
- Hypertension effective treatment coverage (controlled hypertension) in South-East Asia (WHO region) was 13.6% in 2019, according to World Health Organization, Global Health Observatory.
- What is the highest hypertension effective treatment coverage (controlled hypertension) recorded in South-East Asia (WHO region)?
- The highest recorded value was 13.6% in 2019.
- What is the lowest hypertension effective treatment coverage (controlled hypertension) recorded in South-East Asia (WHO region)?
- The lowest recorded value was 1.9% in 1990.
- How does South-East Asia (WHO region) rank for hypertension effective treatment coverage (controlled hypertension)?
- South-East Asia (WHO region) ranks 9th out of 11 groups with data for 2019.
- Is hypertension effective treatment coverage (controlled hypertension) rising or falling in South-East Asia (WHO region)?
- Over the last ten years it is up 70.0%. The long-run trend across the full record is volatile.
- Where does this South-East Asia (WHO region) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).